Patents by Inventor Philip F. Halloran

Philip F. Halloran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TISSUE REJECTION
    Publication number: 20120220484
    Abstract: This document relates to methods and materials involved in detecting tissue rejection (e.g., organ rejection). For example, this document relates to methods and materials involved in the early detection of kidney tissue rejection.
    Type: Application
    Filed: May 7, 2012
    Publication date: August 30, 2012
    Inventor: Philip F. Halloran
  • MOLECULAR SIGNATURE FOR FIBROSIS AND ATROPHY
    Publication number: 20110104700
    Abstract: Materials and Methods involved in assessing tissue fibrosis and atrophy in mammals. For example, materials and methods involved in detecting organ (e.g., kidney) fibrosis/atrophy due to organ rejection are provided, as are materials and methods for determining the extent of fibrosis/atrophy in mammals such as humans, for example.
    Type: Application
    Filed: May 28, 2009
    Publication date: May 5, 2011
    Inventor: Philip F. Halloran
  • ASSESSING TISSUE REJECTION
    Publication number: 20100291563
    Abstract: This document relates to methods and materials involved in assessing tissue rejection (e.g., organ rejection) in mammals. For example, methods and materials involved in detecting tissue rejection (e.g., kidney rejection) are provided, as are methods and materials for determining the extent of rejection in mammals (e.g., humans).
    Type: Application
    Filed: June 25, 2008
    Publication date: November 18, 2010
    Inventor: Philip F. Halloran
  • Tissue Rejection
    Publication number: 20100248251
    Abstract: This document relates to methods and materials involved in detecting tissue rejection (e.g., organ rejection). For example, this document relates to methods and materials involved in the early detection of kidney tissue rejection.
    Type: Application
    Filed: June 9, 2010
    Publication date: September 30, 2010
    Inventor: Philip F. Halloran
  • TISSUE REJECTION BIOMARKERS
    Publication number: 20100190166
    Abstract: This document relates to methods and materials involved in assessing tissue rejection (e.g., organ rejection) in mammals. For example, methods and materials involved in detecting tissue rejection (e.g., kidney rejection) are provided, as are methods and materials for distinguishing types of tissue rejection (e.g., antibody-mediated rejection versus T cell-mediated rejection) in mammals (e.g., humans).
    Type: Application
    Filed: April 18, 2008
    Publication date: July 29, 2010
    Inventor: Philip F. Halloran
  • Tissue Rejection
    Publication number: 20100105066
    Abstract: This document relates to methods and materials involved in detecting tissue rejection (e.g., organ rejection). For example, this document relates to methods and materials involved in the early detection of kidney tissue rejection.
    Type: Application
    Filed: January 5, 2010
    Publication date: April 29, 2010
    Inventor: Philip F. Halloran
  • Tissue rejection
    Patent number: 7666596
    Abstract: This document relates to methods and materials involved in detecting tissue rejection (e.g., organ rejection). For example, this document relates to methods and materials involved in the early detection of kidney tissue rejection.
    Type: Grant
    Filed: May 15, 2006
    Date of Patent: February 23, 2010
    Assignee: University of Alberta
    Inventor: Philip F. Halloran
  • TISSUE REJECTION
    Publication number: 20090176656
    Abstract: This document relates to methods and materials involved in detecting tissue injury and/or rejection (e.g., injury and/or rejection of transplanted tissue). For example, this document relates to methods and materials involved in the early detection of kidney tissue injury.
    Type: Application
    Filed: July 20, 2007
    Publication date: July 9, 2009
    Inventor: Philip F. Halloran
  • Use of insulin-like growth factors I and II for inhibition of inflammatory response
    Patent number: 5843899
    Abstract: The present invention relates to methods for using IGF as inhibitors of inflammatory response, ischemic injury, and organ rejection.
    Type: Grant
    Filed: May 16, 1997
    Date of Patent: December 1, 1998
    Assignee: Ciba-Geigy Corporation
    Inventor: Philip F. Halloran
  • Use of insulin-like growth factors I and II for inhibition of inflammatory response
    Patent number: 5728676
    Abstract: The present invention relates to methods for using IGF as inhibitors of inflammatory response, ischemic injury, and organ rejection.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: March 17, 1998
    Assignee: Ciba-Geigy Corporation
    Inventor: Philip F. Halloran
  • Use of insulin-like growth factors I and II for inhibition of inflammatory response
    Patent number: 5712249
    Abstract: The present invention relates to methods for using IGF as inhibitors of inflammatory response, ischemic injury, and organ rejection.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: January 27, 1998
    Assignee: Ciba-geigy Corporation
    Inventor: Philip F. Halloran